Privium Fund Management B.V. Roivant Sciences Ltd. Transaction History
Privium Fund Management B.V.
- $469 Million
- Q2 2025
A detailed history of Privium Fund Management B.V. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Privium Fund Management B.V. holds 126,923 shares of ROIV stock, worth $2.03 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
126,923
Previous 126,923
-0.0%
Holding current value
$2.03 Million
Previous $1.28 Million
11.72%
% of portfolio
0.3%
Previous 0.34%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$958 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$714 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$628 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$565 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$547 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $11.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...